市場調查報告書

培養皮膚 (皮膚替代品) 市場預測:各類型 (無細胞,同類細胞,自體細胞等),各用途,各地區

Tissue Engineered - Skin Substitutes Market - Forecast (2020 - 2025)

出版商 IndustryARC 商品編碼 422696
出版日期 內容資訊 英文 108 Pages
商品交期: 2-3個工作天內
價格
培養皮膚 (皮膚替代品) 市場預測:各類型 (無細胞,同類細胞,自體細胞等),各用途,各地區 Tissue Engineered - Skin Substitutes Market - Forecast (2020 - 2025)
出版日期: 2020年03月11日內容資訊: 英文 108 Pages
簡介

本報告提供全球培養皮膚 (皮膚替代品) 市場相關調查分析,提供市場形勢,市場動態,策略性分析,市場分析 (各市場區隔),再加上主要企業等相關的系統性資訊。

第1章 培養皮膚 (皮膚替代品) 市場:概要

第2章 摘要整理

第3章 培養皮膚 (皮膚替代品) 市場:形勢

  • 市場佔有率分析
  • 比較分析
  • 產品基準
  • 終端用戶簡介
  • 財務分析前五名

第4章 培養皮膚 (皮膚替代品) 市場:動態

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題
  • 波特的五力分析

第5章 培養皮膚 (皮膚替代品) 市場:策略性分析

  • 價值鏈分析
  • 價格分析
  • 機會分析
  • 產品/市場生命週期分析
  • 供給業者·經銷商

第6章 培養皮膚 (皮膚替代品) 市場:各類型

  • 無細胞
  • 同類細胞
  • 自體細胞
  • 其他

第7章 培養皮膚 (皮膚替代品) 市場:各用途

  • 燒燙傷
  • 糖尿病性/血管性潰瘍
  • 其他

第8章 培養皮膚 (皮膚替代品) 市場:各地區

  • 歐洲
  • 亞太地區
  • 北美
  • 其他

第9章 培養皮膚 (皮膚替代品) 市場:熵

第10章 企業簡介

  • Acelity L.P., Inc.
  • BSN medical
  • Integra LifeSciences Corporation
  • Medtronic (Covidien)
  • Molnlycke Health Care
  • Smith & Nephew plc
  • Organogenesis, Inc.
  • ConVatec
  • 3m Healthcare
  • Integra LifeSciences Corporation

第11章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HCR 0408

Tissue engineered skin substitutes are upcoming alternatives to traditional wound healing strategies and tissue regeneration. Among the tissue engineered organs, skin was the first engineered organ that went from laboratory research to patient care. The global Tissue Engineered Skin Substitutes market in 2017 is valued at $131.5 billion and is anticipated to $335.5 billion by 2023 growing at an estimated value of CAGR of more than 16.9% during the forecast period 2018 to 2023. North America will dominate the Tissue Engineered Skin Substitutes Market in the upcoming years. It will generate revenue of $169.4 billion by 2023 at a CAGR of 16.70%. The application of Tissue engineered skin substitutes is quite effective in the wound closure of patients with diabetic and vascular ulcers. The treatment of diabetic ulcer includes wound care with dressing and antibiotics are given if there is an infection in the body. In wound healing, when the skin is injured, the organic debris should be removed from the injury, and new components should be added and these processes include mutual interactions between the cells, extra cellular matrix, and soluble factors.

Tissue Engineered Skin Substitutes Market Outlook:

Tissue Engineered Skin Substitutes Market is segmented by duration, Anatomical structure, biomaterials, product, application and end user. On the basis of Duration, the Tissue Engineered Skin Substitutes Market is segmented in to Permanent and semi-permanent. On the basis of Anatomical structure, the Tissue Engineered Skin Substitutes market is segmented in to Cellular and Acellular. Acellular type of skin substitutes has a major share in the US market. On the basis of Biomaterials, the Tissue Engineered Skin Substitutes market is segmented in to Autologous, allogeneic, xenogeneic and others. On the basis of Product, the tissue Engineered Skin Substitutes market is categorized in to Synthetic skin substitutes, biosynthetic, biological, Xenografts, Autografts, Amnion and others. Acellular is having the highest market share which is followed by cellular allogeneic which are valued $757 and $294 million in the year 2017 and are estimated to grow with a CAGR of 17.8% and 15.3% during the forecast period 2018 to 2023. On the basis of application, the Tissue Engineered Skin Substitutes market is segmented in to chronic wounds, burns cases, Traumatic wounds, diabetic foot ulcers and others. The Diabetic/Vascular Ulcer segment in 2017 generated a revenue of $716 million. It is projected to reach $2,227. 22 million by 2023 at a CAGR of 17.6%. Hospitals and other healthcare facilities are the end user of the Tissue Engineered Skin Substitutes market.

Tissue Engineered Skin Substitutes Market Growth drivers:

Increasing instances of obesity and diabetes and growth of the elderly population are the major factors driving the growth of Tissue Engineered Skin Substitutes Market. Growing incidences of skin disorders due to burn injuries and increasing incidences of vascular diseases will drive the demand for the Tissue Engineered Skin Substitutes market growth.

Tissue Engineered Skin Substitutes Market Challenges:

The major challenge faced by the Tissue Engineered Skin Substitutes market is large skin defects resulting from burns, trauma, congenital giant nevi, and disease can lead to skin necrosis to achieving skin coverage. Another challenge is the lack of feasible reimbursement policies and inability of reproducing skin appendages which hamper the market growth.

The Stringent rules and regulations across the world concerning ambiguities associated with the environment is one of the significant challenges experienced by Tissue Engineered Skin Substitutes market.

Tissue Engineered Skin Substitutes Market Research Scope:

The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Tissue Engineered Skin Substitutes Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of plastics in the electric vehicle market, and their specific applications in different types of vehicles.

Tissue Engineered Skin Substitutes Market Report: Industry Coverage

Tissue Engineered Skin Substitutes Market- By Duration: Permanent, and Semi-permanent.

Tissue Engineered Skin Substitutes Market - By Anatomical Structure: Cellular, Acellular.

Tissue Engineered Skin Substitutes Market - By Biomaterial: Autologous, Allogeneic, Xenogeneic and others

Tissue Engineered Skin Substitutes Market - By Product: Synthetic Skin substitute, Biosynthetic, Biological, Amnion and others.

Tissue Engineered Skin Substitutes Market - By Technology: Laser assisted bio-printing, 3D, Robotic technology and others

Tissue Engineered Skin Substitutes Market - By Application: Chronic wounds, Burns Cases, Traumatic wounds, Diabetic Foot Ulcers and others.

Tissue Engineered Skin Substitutes Market - By End user: Hospitals and other Healthcare facilities.

The Tissue Engineered Skin Substitutes Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia

Tissue Engineered Skin Substitutes Market Key Players Perspective:

Some of the Key players in this market that have been studied for this report include Acelity L.P. Inc., Smith & Nephew Plc, and Integra Life Sciences Holdings Corporation, 3M Inc., Acelity L.P. Inc., BSN Medical GmbH, Convatec Group Plc, Molnlycke Healthcare AB (Sweden) and few more.

Market Research and Market Trends of Tissue Engineered Skin Substitutes Market:

After the process of skin substitute some patients may experience few side effects like decreased sensitivity, scarring, skin discoloration and frequent infections. To overcome the side effects the medical physicians and surgeons have begun experimenting with the use of skin grafts from genetically modified pig skin which will reduce the side effects caused by the process of skin substitute. This genetically modified grafts are developed a vascular system within four days.

In September 2018, Acelity enters agreement to transition Systagenix manufacturing facility to Scapa Healthcare. This transaction is to increase focus on innovation, development and commercialization of an expanded advanced wound dressing's portfolio to achieve better compete in this large and growing Tissue Engineered Skin Substitutes market.

Researchers from US has fabricated 3D bio printing. 3D bio printing is widely used to construct complex biocompatible structures, researchers from the University of Maryland in Baltimore

are now attempting to extend the technique into the 4D hierarchical micro patterns by exploiting natural soybean oil as the bio ink material. This 4D will help to describe how the micro patterns can be used as biocompatible, shape-changing scaffolds for use in tissue engineering and regeneration applications.

1. Tissue Engineered Skin Substitutes Market - Overview

  • 1.1. Definitions and Scope

2. Tissue Engineered Skin Substitutes Market - Executive summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends by type of Application
  • 2.3. Key Trends segmented by Geography

3. Tissue Engineered Skin Substitutes Market

  • 3.1. Comparative analysis
    • 3.1.1. Product Benchmarking - Top 10 companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value split by Top 10 companies
    • 3.1.4. Patent Analysis - Top 10 companies
    • 3.1.5. Pricing Analysis

4. Tissue Engineered Skin Substitutes Market Forces

  • 4.1. Drivers
  • 4.2. Constraints
  • 4.3. Challenges
  • 4.4. Porters five force model
    • 4.4.1. Bargaining power of suppliers
    • 4.4.2. Bargaining powers of customers
    • 4.4.3. Threat of new entrants
    • 4.4.4. Rivalry among existing players
    • 4.4.5. Threat of substitutes

5. Tissue Engineered Skin Substitutes Market -Strategic analysis

  • 5.1. Value chain analysis
  • 5.2. Opportunities analysis
  • 5.3. Product life cycle

6. Tissue Engineered Skin Substitutes Market- By Duration (Market Size -$Million / $Billion)

  • 6.1. Segment type Size and Market Share Analysis
  • 6.2. Application Revenue and Trends
  • 6.3. Segment Analysis by Type
    • 6.3.1. Permanent
    • 6.3.2. Semi-Permanent

7. Tissue Engineered Skin Substitutes Market- By Anatomical Structure (Market Size -$Million / $Billion)

  • 7.1. Segment type Size and Market Share Analysis
  • 7.2. Application Revenue and Trends
  • 7.3. Segment Analysis by Type
    • 7.3.1. Dermal
    • 7.3.2. Epidermal
    • 7.3.3. Epidermal-dermal (Composite)

8. Tissue Engineered Skin Substitutes Market- By Biomaterial (Market Size -$Million / $Billion)

  • 8.1. Autologous
  • 8.2. Allogeneic
    • 8.2.1. Cellular allogeneic
    • 8.2.2. Acellular allogeneic
  • 8.3. Xenogeneic
  • 8.4. Amnion

9. Tissue Engineered Skin Substitutes Market- By Product (Market Size -$Million / $Billion)

  • 9.1. Synthetic Skin substitutes
    • 9.1.1. Biodegradable
    • 9.1.2. Non-Biodegradable
  • 9.2. Biosynthetic
  • 9.3. Biological
  • 9.4. Amnion
  • 9.5. Others

10. Tissue Engineered Skin Substitutes Market- By Technology (Market Size -$Million / $Billion)

  • 10.1. Laser assisted bio-printing
  • 10.2. 3D
  • 10.3. Robotic Technology
  • 10.4. Others

11. Tissue Engineered Skin Substitutes Market- By Application (Market Size -$Million / $Billion)

  • 11.1. Chronic wounds
  • 11.2. Burns cases
    • 11.2.1. Heat
    • 11.2.2. Electricity
    • 11.2.3. Radiation
  • 11.3. Traumatic Wounds
  • 11.4. Diabetic/Vascular Ulcer
  • 11.5. Others

12. Tissue Engineered Skin Substitutes Market- By End User (Market Size -$Million / $Billion)

  • 12.1. Segment type Size and Market Share Analysis
  • 12.2. Application Revenue and Trends
  • 12.3. Application Segment Analysis by Type
    • 12.3.1. Hospitals
      • 12.3.1.1. Super specialty Hospitals
      • 12.3.1.2. Multi-specialty Hospitals
    • 12.3.2. Other Healthcare Facilities

13. Tissue Engineered Skin Substitutes Market- By Geography (Market Size -$Million / $Billion)

  • 13.1. Tissue Engineered Skin Substitutes Market - North America Segment Research
  • 13.2. North America Market Research (Million / $Billion)
    • 13.2.1. Segment type Size and Market Size Analysis
    • 13.2.2. Revenue and Trends
    • 13.2.3. Application Revenue and Trends by type of Application
    • 13.2.4. Company Revenue and Product Analysis
    • 13.2.5. North America Product type and Application Market Size
      • 13.2.5.1. U.S.
      • 13.2.5.2. Canada
      • 13.2.5.3. Mexico
      • 13.2.5.4. Rest of North America
  • 13.3. Tissue Engineered Skin Substitutes Market- South America Segment Research
  • 13.4. South America Market Research (Market Size -$Million / $Billion)
    • 13.4.1. Segment type Size and Market Size Analysis
    • 13.4.2. Revenue and Trends
    • 13.4.3. Application Revenue and Trends by type of Application
    • 13.4.4. Company Revenue and Product Analysis
    • 13.4.5. South America Product type and Application Market Size
      • 13.4.5.1. Brazil
      • 13.4.5.2. Venezuela
      • 13.4.5.3. Argentina
      • 13.4.5.4. Ecuador
      • 13.4.5.5. Peru
      • 13.4.5.6. Colombia
      • 13.4.5.7. Costa Rica
      • 13.4.5.8. Rest of South America
  • 13.5. Tissue Engineered Skin Substitutes Market- Europe Segment Research
  • 13.6. Europe Market Research (Market Size -$Million / $Billion)
    • 13.6.1. Segment type Size and Market Size Analysis
    • 13.6.2. Revenue and Trends
    • 13.6.3. Application Revenue and Trends by type of Application
    • 13.6.4. Company Revenue and Product Analysis
    • 13.6.5. Europe Segment Product type and Application Market Size
      • 13.6.5.1. U.K
      • 13.6.5.2. Germany
      • 13.6.5.3. Italy
      • 13.6.5.4. France
      • 13.6.5.5. Netherlands
      • 13.6.5.6. Belgium
      • 13.6.5.7. Spain
      • 13.6.5.8. Denmark
      • 13.6.5.9. Rest of Europe
  • 13.7. Tissue Engineered Skin Substitutes Market- APAC Segment Research
  • 13.8. APAC Market Research (Market Size -$Million / $Billion)
    • 13.8.1. Segment type Size and Market Size Analysis
    • 13.8.2. Revenue and Trends
    • 13.8.3. Application Revenue and Trends by type of Application
    • 13.8.4. Company Revenue and Product Analysis
    • 13.8.5. APAC Segment - Product type and Application Market Size
      • 13.8.5.1. China
      • 13.8.5.2. Australia
      • 13.8.5.3. Japan
      • 13.8.5.4. South Korea
      • 13.8.5.5. India
      • 13.8.5.6. Taiwan
      • 13.8.5.7. Malaysia
      • 13.8.5.8. Hong Kong
      • 13.8.5.9. Rest of APAC
  • 13.9. Tissue Engineered Skin Substitutes Market- Middle East Segment and Africa Segment Research
  • 13.10. Middle East & Africa Market Research (Market Size -$Million / $Billion)
    • 13.10.1. Segment type Size and Market Size Analysis
    • 13.10.2. Revenue and Trend Analysis
    • 13.10.3. Application Revenue and Trends by type of Application
    • 13.10.4. Company Revenue and Product Analysis
    • 13.10.5. Middle East Segment Product type and Application Market Size
      • 13.10.5.1. Israel
      • 13.10.5.2. Saudi Arabia
      • 13.10.5.3. UAE
    • 13.10.6. Africa Segment Analysis
      • 13.10.6.1. South Africa
      • 13.10.6.2. Rest of Middle East & Africa

14. Tissue Engineered Skin Substitutes Market - Entropy

  • 14.1. New product launches
  • 14.2. M&A's, collaborations, JVs and partnerships

15. Tissue Engineered Skin Substitutes Market Company Analysis

  • 15.1. Market Share, Company Revenue, Products, M&A, Developments
  • 15.2. Celity L.P. Inc.
  • 15.3. Smith & Nephew Plc
  • 15.4. Integra Life Sciences Holdings Corporation
  • 15.5. 3M Inc.
  • 15.6. BSN Medical GmbH
  • 15.7. Convatec Group Plc
  • 15.8. Molnlycke Healthcare AB
  • 15.9. Company 8
  • 15.10. Company 9
  • 15.11. Company 10 and more

"*Financials would be provided on a best efforts basis for private companies"

16. Tissue Engineered Skin Substitutes Market -Appendix

  • 16.1. Abbreviations
  • 16.2. Sources